[Cryopreserved substance, isolated from human fetal liver, restore biochemical processes in acute liver failure].
Recovery processes dynamics in liver when treating experimental acute hepatic insufficiency (AHI) of various etiology by using cryopreserved biopreparations, obtained from human embryo liver of different terms of development (10-12 weeks), human fetuses (22-24 week of development).
Subbota
N P
NP
Institute for Problems of Cryobiology and Cryomedicine NAS of Ukraine, Kharkov.
Pashinskiĭ
P P
PP
Kebkalo
A B
AB
D000818:Animals; D015925:Cryopreservation; D006801:Humans; D015227:Lipid Peroxidation; D008099:Liver / Q000196:embryology* / Q000378:metabolism*; D017114:Liver Failure, Acute / Q000097:blood / Q000378:metabolism / Q000628:therapy*; D008112:Liver Glycogen / Q000097:blood; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
D008112:Liver Glycogen; D008315:Malondialdehyde